ImmunityBio, Inc.

IBRX

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001326110

SEC filings (opens in a new tab)

No open-market purchases or sales by ImmunityBio, Inc. insiders were filed in the last 90 days; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding ImmunityBio, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of IBRX: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Of which not filed for Q1 2022	Q1 2022	Change
Holders	141	1	149	+9
Shares	34.5M	250	35.6M	+1.13M (+3.3%)
Value	$209.7M	$1.00K	$199.8M	−$9.87M (−4.7%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held ImmunityBio, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to IBRX in Q1 2022
Institution	Shares	Value	% of portfolio
Oracle Investment Management Inc	400,013	$2.24M	0.45%
Advisory Services Network, LLC	113,299	$636.0K	0.02%
FMR LLC	109,434	$614.0K	0.00%
Winning Points Advisors, LLC	60,126	$339.0K	0.26%
Stonehage Fleming Financial Services Holdings Ltd	60,000	$336.0K	0.01%
Two Sigma Securities, LLC	40,502	$227.0K	0.03%
HRT Financial LP	37,842	$212.0K	0.00%
Corton Capital Inc.	36,843	$207.0K	0.09%
Bayesian Capital Management, LP	31,300	$176.0K	0.03%
Wolverine Trading, LLC	26,082	$154.0K	0.00%
Delphia (USA) Inc.	25,504	$143.0K	0.11%
Steel Peak Wealth Management LLC	25,200	$141.0K	0.01%
Man Group plc	23,469	$132.0K	0.00%
Martingale Asset Management L P	18,425	$104.0K	0.00%
Compagnie Lombard Odier SCmA	14,000	$79.0K	0.00%
Commonwealth Equity Services, LLC	13,108	$73.0K	0.00%
Barclays PLC	11,641	$66.0K	0.00%
Toroso Investments, LLC	11,219	$63.0K	0.00%
Wealth Effects LLC	11,000	$62.0K	0.03%
Sigma Planning Corp	10,450	$59.0K	0.00%
Amalgamated Bank	8,577	$48.0K	0.00%
Amalgamated Financial Corp.	8,577	$48.0K	0.00%
Nisa Investment Advisors, LLC	1,600	$9.00K	0.00%
Prospera Financial Services Inc	1,559	$9.00K	0.00%
Worth Asset Management, LLC	1,650	$5.00K	0.00%
Aquatic Capital Management LLC	400	$2.00K	0.00%
Disciplined Investments, LLC	5	$0	0.00%
Cordant, Inc.	13	$0	0.00%
SJS Investment Consulting Inc.	1	$0	0.00%

Sold out (20)

Institutions that held ImmunityBio, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of IBRX in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Renaissance Technologies LLC	304,900	$1.85M
Sculptor Capital LP	153,300	$932.0K
Mutual of America Capital Management LLC	117,439	$714.0K
Russell Investments Group, Ltd.	113,723	$691.0K
Prudential Financial Inc	75,365	$459.0K
Occudo Quantitative Strategies LP	47,850	$291.0K
GM Advisory Group, Inc.	19,057	$116.0K
XTX Topco Ltd	19,159	$116.0K
Ergoteles LLC	17,264	$105.0K
AXA S.A.	16,500	$100.0K
Alpine Global Management, LLC	14,805	$90.0K
Landscape Capital Management, L.L.C.	11,670	$71.0K
Dimensional Fund Advisors LP	10,221	$62.0K
FNY Investment Advisers, LLC	5,000	$30.0K
Hantz Financial Services, Inc.	740	$4.00K
CWM, LLC	100	$1.00K
Quadrant Capital Group LLC	145	$1.00K
RGT Wealth Advisors, LLC	200	$1.00K
Patriot Financial Group Insurance Agency, LLC	19	$0
Dark Forest Capital Management LP	46	$0

Not filed for Q1 2022 yet (1)

Institutions that held ImmunityBio, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IBRX in Q4 2021 that haven't filed for Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Carroll Financial Associates, Inc.	250	$1.00K